文献速递慢性肾脏病

美国三个医疗系统电子健康记录中肾脏病家族史的患病率及意义

Prevalence and significance of family history of kidney disease in the electronic health record in three United States health systems.
PubMed 文献 · Kidney Int · 2026-09-28

该横断面研究纳入美国三个医疗系统2020-2023年接受初级保健的1,130,961名18-80岁成人,从结构化电子健康记录字段和家族史部分注释中的相关检索词确定CKD和肾衰竭家族史。CKD家族史报告率仅5.4%,低于糖尿病家族史39.1%和高血压家族史35.3%;CKD家族史与CKD(合并OR 1.39,95%CI 1.24-1.57)和肾衰竭(合并OR 3.15,95%CI 1.92-5.22)独立相关。

要点

  • CKD家族史报告率5.4%,远低于糖尿病和高血压家族史。
  • CKD家族史与CKD和肾衰竭风险独立相关。
  • 应改进CKD家族史的系统记录以识别高危个体。

核心结论

  • CKD家族史相对于其他心血管代谢疾病被低报,且与CKD和肾衰竭正相关。
  • 改进CKD家族史的系统记录可能改善高危个体的早期识别并助力精准医学。

研究设计与样本

  • 横断面研究,纳入美国Geisinger、纽约大学Langone健康中心和犹他大学健康中心2020-2023年初级保健的1,130,961名18-80岁成人。
  • 从电子健康记录结构化家族史字段和家族史部分注释中的相关检索词确定CKD和肾衰竭家族史。
  • 使用经验证的电子健康记录CKD表型计算CKD家族史的合并患病率,并用多变量logistic回归评估关联,通过随机效应荟萃分析得出合并估计值。

主要发现

  • 87.2%的个体至少记录了一个家族史字段,CKD家族史报告率为5.4%,而糖尿病家族史为39.1%,高血压家族史为35.3%。
  • CKD家族史患病率随CKD分期进展总体升高,从2期CKD的6.6%到3B期的10.3%,再到5期的17.7%。
  • 男性和40岁以下个体CKD家族史报告率较低。
  • CKD家族史与CKD显著相关(合并OR 1.39,95%CI 1.24-1.57),与肾衰竭显著相关(合并OR 3.15,95%CI 1.92-5.22),且独立于人口学和临床因素。

临床怎么用

  • 在肾内科评估中应主动询问并系统记录CKD家族史,尤其对40岁以下男性和早期CKD患者。
  • CKD家族史阳性者应视为CKD和肾衰竭高危人群,加强监测和早期干预。

局限性

  • 横断面设计无法确定因果关系。
  • 家族史基于电子健康记录记录,可能存在错分和报告不足。
  • 研究仅纳入美国三个医疗系统的初级保健成人,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Family history is a key predictor of chronic kidney disease (CKD) and kidney failure, yet its documentation in electronic health records (EHRs) remains poorly characterized. Here, we examined the prevalence of kidney-related family history across three large United States. health systems and assessed associations with kidney disease outcomes. METHODS: We conducted a cross-sectional study of 1,130,961 adults (age 18-80) receiving primary care at Geisinger, New York University Langone Health, and University of Utah Health from 2020-2023. Family history of CKD and kidney failure was ascertained from structured EHR fields and relevant search terms in comments in the family history section. Pooled prevalence of family history CKD was calculated overall and by CKD stage, using a validated EHR-based CKD phenotype. Associations between CKD family history and personal history of CKD and kidney failure were assessed using multivariable logistic regression, with pooled estimates derived via random-effects meta-analysis. RESULTS: At least one family history field was recorded in 87.2% of individuals, with lower reporting of CKD family history (5.4%), compared to family history of diabetes (39.1%) or hypertension (35.3%). Prevalence of CKD family history was generally higher with advancing CKD stage, ranging from 6.6% for stage 2 CKD, to 10.3% for stage 3B CKD, and 17.7% for stage 5 CKD. Men and individuals under 40 years had lower family history of CKD reporting. Family history of CKD was significantly associated with CKD (pooled odds ratio 1.39, 95% confidence interval: 1.24, 1.57) and kidney failure (pooled odds ratio 3.15, 95% confidence interval: 1.92, 5.22) across cohorts, independent of demographic and clinical factors. CONCLUSIONS: CKD family history is underreported relative to other cardiometabolic conditions and positively associated with CKD and kidney failure. Improving systematic recording of CKD family history may improve early identification of high-risk individuals and inform precision medicine approaches to CKD prevention and care.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Bucaloiu A, Surapaneni A, Mehta S, et al. Prevalence and significance of family history of kidney disease in the electronic health record in three United States health systems. Kidney Int. 2026. PMID: 42805334. doi:10.1016/j.kint.2026.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。